Home › Trial NCT05554367
Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial
- Trial IDNCT05554367
- StatusActive Not Recruiting
- PhasePhase 2
- Study typeInterventional
- SponsorNational Cancer Institute (NCI)
- Enrollment199
- Start date2023-12-13
- ConditionsExocrine Pancreas Carcinoma · Malignant Solid Neoplasm · Ovarian Low Grade Serous Adenocarcinoma · Stage IV Ovarian Cancer AJCC v8 · Stage IV Pancreatic Cancer AJCC v8
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.